• 作者：Carlo Pappone ; ^{cpappone@gvm-vmc.it} ; Vincenzo Santinelli
• 关键词：ARF ; ablació ; n por radiofrecuencia ; AVPC ; ablació ; n venosa pulmonar circular ; FA ; fibrilació ; n auricular ; FAA ; fá ; rmacos antiarrí ; tmicos ; TA ; taquicardia auricular ; VP ; vena pulmonar
• 刊名：Revista Espa?ola de Cardiolog¡§aa
• 出版年：2012
• 出版时间：June, 2012
• 年：2012
• 卷：65
• 期：6
• 页码：560-569
• 全文大小：3660 K

Atrial fibrillation is the commonest cardiac arrhythmia, with significant morbidity related to symptoms, heart failure, and thromboembolism, which is associated with excess mortality. Over the past 10 years, many centers worldwide have reported high success rates and few complications after a single ablation procedure in patients with paroxysmal atrial fibrillation. Recent studies indicate a short-term and long-term superiority of catheter ablation as compared with conventional antiarrhythmic drug therapy in terms of arrhythmia recurrence, quality of life, and arrhythmia progression. As a result, catheter ablation is evolving to a front-line therapy in many patients with atrial fibrillation. However, in patients with persistent long-standing atrial fibrillation catheter ablation strategy is more complex and time-consuming, frequently requiring repeat procedures to achieve success rates as high as in paroxysmal atrial fibrillation. In the near future, however, with growing experience and evolving technology, catheter ablation of atrial fibrillation may be extended also to patients with long-standing atrial fibrillation.

Full English text available from: